Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (131-140 of 243) with videos related to

Pageof 25
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2020
Early Treatment Response Assessment Using <sup>18</sup>F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide ChemotherapyGarry Ceccon, Philipp Lohmann, Jan-Michael Werner, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastomaNiklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
German Medical Science : GMS E-Journal|June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysisKatrin Patrij, Marcel Reiser, Luise Wätzel, et al.
Neuro-Oncology|April 8, 2021
Prognostic factors in leptomeningeal metastasesEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Neuro-Oncology Practice|May 11, 2026
Proof of concept: Portable ultra-low-field MRI for the assessment of brain tumorsThomas Zeyen, Hemmen Sabir, Tobias Bauer, et al.
Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Neuro-Oncology|December 28, 2020
Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumorsEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Neuro-Oncology|July 23, 2021
Erratum to: Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumorsEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Cancer Research|February 20, 2007
Imaging-guided gene therapy of experimental gliomasAndreas H Jacobs, Maria Adele Rueger, Alexandra Winkeler, et al.
Pageof 25

Showing results (131-140 of 243) with videos related to

Sort By:
Pageof 25
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2020
Early Treatment Response Assessment Using <sup>18</sup>F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide ChemotherapyGarry Ceccon, Philipp Lohmann, Jan-Michael Werner, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastomaNiklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
German Medical Science : GMS E-Journal|June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysisKatrin Patrij, Marcel Reiser, Luise Wätzel, et al.
Neuro-Oncology|April 8, 2021
Prognostic factors in leptomeningeal metastasesEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Neuro-Oncology Practice|May 11, 2026
Proof of concept: Portable ultra-low-field MRI for the assessment of brain tumorsThomas Zeyen, Hemmen Sabir, Tobias Bauer, et al.
Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Neuro-Oncology|December 28, 2020
Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumorsEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Neuro-Oncology|July 23, 2021
Erratum to: Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumorsEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Cancer Research|February 20, 2007
Imaging-guided gene therapy of experimental gliomasAndreas H Jacobs, Maria Adele Rueger, Alexandra Winkeler, et al.
Pageof 25